Rogers, E. S., MacLeod, R. D., Stewart, J., Bird, S. P., & Keogh, J. W. (2011). A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study. BioMed Central.

Rogers, Elaine S., Roderick D. MacLeod, Joanna Stewart, Stephen P. Bird, e Justin WL Keogh. A Randomised Feasibility Study of EPA and Cox-2 Inhibitor (Celebrex) Versus EPA, Cox-2 Inhibitor (Celebrex), Resistance Training Followed By Ingestion of Essential Amino Acids High in Leucine in NSCLC Cachectic Patients - ACCeRT Study. BioMed Central, 2011.

Rogers, Elaine S., et al. A Randomised Feasibility Study of EPA and Cox-2 Inhibitor (Celebrex) Versus EPA, Cox-2 Inhibitor (Celebrex), Resistance Training Followed By Ingestion of Essential Amino Acids High in Leucine in NSCLC Cachectic Patients - ACCeRT Study. BioMed Central, 2011.